|3Feb 4, 2:00 PM ET

CS Diagnostics Pharma GmbH 3

3 · CS DIAGNOSTICS CORP. · Filed Feb 4, 2026

Insider Transaction Report

Form 3
Period: 2025-12-31
Holdings
  • Common Stock

    104,507,800
Signature
/s/ Thomas Fahrhoefer|2026-02-04

Documents

1 file
  • 3
    marketforms-72029.xmlPrimary

    PRIMARY DOCUMENT